[Non-A, non-B Hepatitis. A progress report]. 1983

L Bianchi, and H P Spichtin, and F Gudat

The present state of the art in non-A, non-B hepatitis is reviewed. Eight years of world-wide efforts in research have not yielded a definite characterization of agent(s) and markers of this viral infection. Diagnosis is therefore established mainly by exclusion of the hepatitis viruses A and B, Epstein-Barr virus and cytomegalovirus, and drug-induced liver disease. Currently available serological, electron microscopic, immune electron microscopic and clinical information on non-A, non-B hepatitis in chimpanzee and man is briefly reviewed. Some light microscopic features provisionally regarded as suggestive of non-A, non-B hepatitis in man are presented. In daily practice the diagnostic tools in the near future will largely depend upon progress in the elaboration of suitable serological test systems and on further confirmation of microscopic findings, unless an unexpected breakthrough occurs through identification and characterization of the virus(es) in non-A, non-B infection.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D002679 Pan troglodytes The common chimpanzee, a species of the genus Pan, family HOMINIDAE. It lives in Africa, primarily in the tropical rainforests. There are a number of recognized subspecies. Chimpanzee,Chimpanzee troglodytes,Chimpanzee troglodyte,Chimpanzees,Pan troglodyte,troglodyte, Pan,troglodytes, Chimpanzee
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006518 Hepatitis Viruses Any of the viruses that cause inflammation of the liver. They include both DNA and RNA viruses as well viruses from humans and animals. Hepatitis Virus, Marmoset,Hepatitis Virus,Hepatitis Viruses, Marmoset,Marmoset Hepatitis Virus,Marmoset Hepatitis Viruses,Virus, Hepatitis,Virus, Marmoset Hepatitis,Viruses, Hepatitis,Viruses, Marmoset Hepatitis
D006525 Hepatitis, Viral, Human INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D). Viral Hepatitis, Human,Human Viral Hepatitides,Human Viral Hepatitis,Viral Hepatitides, Human
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

L Bianchi, and H P Spichtin, and F Gudat
November 1982, Revista clinica espanola,
L Bianchi, and H P Spichtin, and F Gudat
January 1983, Developments in biological standardization,
L Bianchi, and H P Spichtin, and F Gudat
January 1982, Journal of medical virology,
L Bianchi, and H P Spichtin, and F Gudat
May 1979, Revue medicale de Liege,
L Bianchi, and H P Spichtin, and F Gudat
October 1987, The Journal of infectious diseases,
L Bianchi, and H P Spichtin, and F Gudat
March 1982, Journal of the Iowa Medical Society,
L Bianchi, and H P Spichtin, and F Gudat
October 1981, The Journal of the Association of Physicians of India,
L Bianchi, and H P Spichtin, and F Gudat
August 1988, JPMA. The Journal of the Pakistan Medical Association,
L Bianchi, and H P Spichtin, and F Gudat
January 1975, The American journal of the medical sciences,
L Bianchi, and H P Spichtin, and F Gudat
July 1994, Hepatology (Baltimore, Md.),
Copied contents to your clipboard!